| N-acetyllactosamine synthase | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||
| EC no. | 2.4.1.90 | ||||||||
| CAS no. | 9054-94-8 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| |||||||||
N-acetyllactosamine synthase is a galactosyltransferase enzyme. [1] [2] [3] [4] [5] [6] It is a component of lactose synthase [ citation needed ] This enzyme modifies the connection between two molecule UDP-galactose and N-actyl-D-glucosamine and generates two different molecules UDP and N-acetyllactosamine as products. [7] The main function of the enzyme is associated with the biosynthesis of glycoproteins and glycolipids in both human and animals. [7] In human, the activity of this enzyme can be found in Golgi apparatus. [7]
It is classified under EC 2.4.1.90.
The lack of this enzyme leads to glycolysation [7] [8] [9] which is a serious neurological disease. The nature of the disease causes fluid in the brain, abnormal inflammatory response and abnormal bleeding issues. [7] [8] [9]